Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Drejer J, Larsson OM, Schousboe A
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
(4) LG + TGF1 (10 ng/mL)
I am 41 now
DHEA supplementation confers no additional benefit to that of growth hormone on pregnancy and live birth rates in IVF patients categorized as poor prognosis
PMID: 20417778
